Page contentsPage contents Key facts Decision Key facts Active substance clotrimazole Therapeutic area Oto-rhino-laryngology Decision number P/0332/2023 PIP number EMEA-003431-PIP01-23 Pharmaceutical form(s) Ear drops, solution Condition(s) / indication(s) Treatment of acute otitis externa Route(s) of administration Auricular use Contact for public enquiries Laboratorios Salvat, S.A.E-mail: regulatory@svt.com Tel. +34 933946400 Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 09/08/2023 Compliance check done No Decision P/0332/2023 : EMA decision of 9 August 2023 on the granting of a product specific waiver for clotrimazole (EMEA-003431-PIP01-23)Reference Number: EMA/347894/2023 English (EN) (186.07 KB - PDF)First published: 13/09/2024 View Share this page